NCT06808230View on ClinicalTrials.gov

Cocoa Extract for Migraine Trial

NARecruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

June 23, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Migraine
Interventions
DIETARY_SUPPLEMENT

Cocoa extract

Cocoa extract manufactured as 250 mg capsules

DIETARY_SUPPLEMENT

Cocoa extract placebo

Cocoa extract placebo

Trial Locations (1)

02115

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Brigham and Women's Hospital

OTHER